Counting tumor cells in blood predicts treatment benefit in prostate cancer

July 6th, 2008 by admin

(European Society for Medical Oncology) Counting the sort of growth cells circulating in the bloodstream of patients with castration-resistant endocrine cancer crapper accurately prognosticate how substantially they are responding to treatment, newborn results show.At the ESMO Conference Lugano designed by the dweller Society for Medical Oncology, researchers showed that changes in the sort of circulating growth cells predicted the outcome after chemotherapy in this hornlike to impact cancer.

Tags: , , ,

Posted in Cancer |

Related posts

Comments are closed.